DOI: 10.12890/2020_001702

Thrombocytopenia in the Course of COVID-19 Infection

Authors

  • Noel Lorenzo-Villalba Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Abrar-Ahmad Zulfiqar Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Marc Auburtin Service de Médecine Interne, Centre Hospitalier d’Epinal, Epinal, France
  • Marie Helene Schuhmacher Service de Médecine Interne, Centre Hospitalier d’Epinal, Epinal, France
  • Alain Meyer Service de Rhumatologie, Hôpitaux Universitaires de Strasboug, Strasbourg, France
  • Yasmine Maouche Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • Olivier Keller Service de Médecine Interne, Centre Hospitalier de Haguenau, Haguenau, France
  • Emmanuel Andres Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

noellorenzo@gmail.com

Keywords

COVID-19, thrombocytopenia, immune thrombocytopenia, immunoglobulins, eltrombopag

Abstract

We report three cases of severe thrombocytopenia during COVID-19 infection associated with either cutaneous purpura or mucosal bleeding. The initial investigations ruled out other causes of thrombocytopenia. Two of the patients were treated with intravenous immunoglobulins and eltrombopag, while the third recovered spontaneously. A good clinical and biological response was achieved in all patients leading to hospital discharge.

View the entire article

Downloads

Published

2020-05-07

How to Cite

1.
Lorenzo-Villalba N, Zulfiqar A-A, Auburtin M, Schuhmacher MH, Meyer A, Maouche Y, et al. Thrombocytopenia in the Course of COVID-19 Infection. EJCRIM [Internet]. 2020 May 7 [cited 2026 Nov. 3];7(6). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1702

Most read articles by the same author(s)

1 2 3 > >>